Literature DB >> 4357601

Attempts to detect homologous autointerference in vivo with influenza virus and vesicular stomatitis virus.

J J Holland, M Doyle.   

Abstract

Von Magnus particles of influenza virus and defective interfering T particles of vesicular stomatitis virus were unable to provide significant protection of mice from disease or death when inoculated intranasally or intracerebrally along with moderate or high doses of homologous infectious challenge virus. However, yields of infectious virus from the affected organs were reduced as compared to controls inoculated with infectious virus alone. Serial intracerebral passage of vesicular stomatitis virus in mouse brain at high doses failed to produce T particles detectable by in vitro autointerference assays on BHK(21) cells, whether or not T particles were introduced along with B virions at the first passage. When very low challenge doses of infectious B virions were inoculated intracerebrally along with high doses of homologous defective particles, there was significant prolongation of life, although most mice died eventually of slowly progressing disease. Also, the virus yields in the brains of these mice were significantly reduced, and virus was no longer detectable in the brains of "protected" mice surviving for 10 days or more. Our results suggest that although homologous autointerference does occur in vivo, it is a more complex phenomenon than in vitro cell culture experiments might indicate.

Entities:  

Mesh:

Year:  1973        PMID: 4357601      PMCID: PMC422716          DOI: 10.1128/iai.7.4.526-531.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Homologous interference by incomplete Sendai virus particles: changes in virus-specific ribonucleic acid synthesis.

Authors:  A Portner; D W Kingsbury
Journal:  J Virol       Date:  1971-10       Impact factor: 5.103

2.  Polysomal ribonucleic acid of vesicular stomatitis virus-infected HeLa cells.

Authors:  J A Mudd; D F Summers
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

3.  Defective interfering particles of poliovirus. I. Isolation and physical properties.

Authors:  C N Cole; D Smoler; E Wimmer; D Baltimore
Journal:  J Virol       Date:  1971-04       Impact factor: 5.103

4.  Heterogeneity of polyoma virus DNA: isolation and characterization of non-infectious small supercoiled molecules.

Authors:  M E Blackstein; C P Stanners; A J Farmilo
Journal:  J Mol Biol       Date:  1969-06-14       Impact factor: 5.469

5.  Vesicular stomatitis virus RNA: complementarity between infected cell RNA and RNA's from infectious and autointerfering viral fractions.

Authors:  F L Schaffer; A J Hackett; M E Soergel
Journal:  Biochem Biophys Res Commun       Date:  1968-06-10       Impact factor: 3.575

6.  Defective T particles of vesicular stomatitis virus. II. Biologic role in homologous interference.

Authors:  A S Huang; R R Wagner
Journal:  Virology       Date:  1966-10       Impact factor: 3.616

7.  Incomplete growth of simian virus 40 in African green monkey kidney culture induced by serial undiluted passages.

Authors:  S Uchida; S Watanabe; M Kato
Journal:  Virology       Date:  1966-01       Impact factor: 3.616

8.  Defective T particles of vesicular stomatitis virus. I. Preparation, morphology, and some biologic properties.

Authors:  A S Huang; J W Greenawalt; R R Wagner
Journal:  Virology       Date:  1966-10       Impact factor: 3.616

9.  Defective viral particles and viral disease processes.

Authors:  A S Huang; D Baltimore
Journal:  Nature       Date:  1970-04-25       Impact factor: 49.962

10.  Replication of influenza virus in a continuous cell line: high yield of infective virus from cells inoculated at high multiplicity.

Authors:  P W Choppin
Journal:  Virology       Date:  1969-09       Impact factor: 3.616

View more
  17 in total

1.  In vivo interference in vesicular stomatitis virus infection.

Authors:  J Crick; F Brown
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

Review 2.  Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?

Authors:  Nigel J Dimmock; Andrew J Easton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

3.  Prophylaxis and immunization in mice by use of virus-free defective T particles to protect against intracerebral infection by vesicular stomatitis virus.

Authors:  M Doyle; J J Holland
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

4.  Induction and biological properties of defective interfering particles of rabies virus.

Authors:  T J Wiktor; B Dietzschold; R N Leamnson; H Koprowski
Journal:  J Virol       Date:  1977-02       Impact factor: 5.103

Review 5.  Pathogenicity of influenza virus.

Authors:  C Sweet; H Smith
Journal:  Microbiol Rev       Date:  1980-06

6.  Murine influenza virus encephalomyelitis. III. Effect of defective interfering virus particles.

Authors:  E T Gamboa; D H Harter; P E Duffy; K C Hsu
Journal:  Acta Neuropathol       Date:  1976-03-15       Impact factor: 17.088

7.  "Defective" mutations of hepatitis D viruses in chronic hepatitis D patients.

Authors:  Jaw-Ching Wu; Sheng-Chieh Hsu; Shen-Yung Wang; Yi-Hsiang Huang; I-Jane Sheen; Hsuan-Hui Shih; Wan-Jr Syu
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

8.  Production of defective interfering virus in the brains of mice by an avirulent, in contrast with a virulent, strain of Semliki forest virus.

Authors:  C G Woodward; H Smith
Journal:  Br J Exp Pathol       Date:  1975-08

9.  Detection of vesicular stomatitis virus RNA and its defective-interfering particles in individual mouse brains.

Authors:  D R Cave; F S Hagen; E L Palma; A S Huang
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

10.  Temperature-sensitive mutants of rabies virus in mice: a mutant (ts2) revertant mixture selectively pathogenic by the peripheral route of inoculation.

Authors:  H F Clark; S Ohtani
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.